Inozyme Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inozyme Pharma and buy or sell other stocks, ETFs, and their options commission-free!About INZY
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.
CEODoug Treco Treco, PhD
CEODoug Treco Treco, PhD
Employees67
Employees67
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees67
Employees67
INZY Key Statistics
Market cap257.88M
Market cap257.88M
Price-Earnings ratio-2.38
Price-Earnings ratio-2.38
Dividend yield—
Dividend yield—
Average volume712.81K
Average volume712.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.24
52 Week high$6.24
52 Week low$0.721
52 Week low$0.721
Stock Snapshot
Inozyme Pharma(INZY) stock is priced at $4.00, giving the company a market capitalization of 257.88M. It carries a P/E multiple of -2.38.
On 2025-12-14, Inozyme Pharma(INZY) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 712.81K.
Over the past 52 weeks, Inozyme Pharma(INZY) stock has traded between a high of $6.24 and a low of $0.72.
Over the past 52 weeks, Inozyme Pharma(INZY) stock has traded between a high of $6.24 and a low of $0.72.
People also own
Based on the portfolios of people who own INZY. This list is generated using Robinhood data, and it’s not a recommendation.